THE USE AND OUTCOMES OF MEN WITH NCCN FAVORABLE INTERMEDIATE RISK PROSTATE CANCER MANAGED WITH ACTIVE SURVEILLANCE

被引：0
|
作者：
Paudel, Roshan
Madan, Raghav
Qi, Ji
Cher, Michael
Lane, Brian
George, Arvin
Semerjian, Alice
Ginsburg, Kevin
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP43-11
引用
收藏
页码：E745 / E745
页数：1
相关论文
共 50 条
  • [21] Trends in Active Surveillance for Men With Intermediate-Risk Prostate Cancer
    Diven, Marshall A.
    Tshering, Lhaden
    Ma, Xiaoyue
    Hu, Jim C.
    Barbieri, Christopher
    McClure, Timothy
    Nagar, Himanshu
    [J]. JAMA NETWORK OPEN, 2024, 7 (08)
  • [22] ACTIVE SURVEILLANCE IN 853 MEN WITH LOW AND INTERMEDIATE RISK PROSTATE CANCER
    Aning, Jonathan
    Peacock, Michael
    Zargar, Homi
    Harriman, David
    McKenzie, Michael
    Black, Peter
    So, Alan
    Goldenberg, Larry
    Gleave, Martin
    [J]. JOURNAL OF UROLOGY, 2014, 191 (04): : E347 - E347
  • [23] PREDICTED RISK OF PROSTATE CANCER-SPECIFIC MORTALITY ON ACTIVE SURVEILLANCE FOR MEN WITH FAVORABLE INTERMEDIATE RISK PROSTATE CANCER: RESULTS FROM THE SEARCH DATABASE
    Kuhlmann, Paige K.
    Oyekunle, Taofik
    Howard, Lauren E.
    Klaassen, Zachary
    Amling, Christopher L.
    Aronson, William J.
    Cooperberg, Matthew R.
    Kane, Christopher J.
    Terris, Martha K.
    Freedland, Stephen J.
    [J]. JOURNAL OF UROLOGY, 2020, 203 : E1289 - E1289
  • [24] Outcomes of Active Surveillance for Men With Intermediate Risk Prostate Cancer: A Population-Based Analysis REPLY
    Chandrasekar, Thenappan
    Bowler, Nicholas
    Schneider, Adam
    Goldberg, Hanan
    Mark, James R.
    Trabulsi, Edouard J.
    Lallas, Costas D.
    Gomella, Leonard G.
    [J]. UROLOGY, 2021, 155 : 109 - 109
  • [25] Use and early mortality outcomes of active surveillance in patients with intermediate-risk prostate cancer
    Butler, Santino S.
    Mahal, Brandon A.
    Lamba, Nayan
    Mossanen, Matthew
    Martin, Neil E.
    Mouw, Kent W.
    Nguyen, Paul L.
    Muralidhar, Vinayak
    [J]. CANCER, 2019, 125 (18) : 3164 - 3171
  • [26] Active Surveillance for Favorable Risk Prostate Cancer PRO
    Klotz, Laurence
    [J]. JOURNAL OF UROLOGY, 2009, 182 (06): : 2565 - 2566
  • [27] Active Surveillance for Intermediate Risk Prostate Cancer
    Laurence Klotz
    [J]. Current Urology Reports, 2017, 18
  • [28] Active Surveillance for Intermediate Risk Prostate Cancer
    Klotz, Laurence
    [J]. CURRENT UROLOGY REPORTS, 2017, 18 (10)
  • [29] ACTIVE SURVEILLANCE IN INTERMEDIATE RISK PROSTATE CANCER
    Chandrasekar, Thenappan
    Herrera-Caceres, Jaime O.
    Klotz, Laurence
    [J]. ARCHIVOS ESPANOLES DE UROLOGIA, 2019, 72 (02): : 157 - 166
  • [30] SURVEILLANCE RATES FOR FAVORABLE INTERMEDIATE AND LOW RISK PROSTATE CANCER
    Frankel, Jason
    Jung, Nathan
    Ferenczi, Basil
    Flores, John Paul
    Porter, Christopher
    [J]. JOURNAL OF UROLOGY, 2020, 203 : E149 - E149
12345